Mary Geldernick
Obstetrics & Gynecology · New Braunfels, TXNPI 1104987510
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations.
Across 164 payments — averaging $14.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avion Pharmaceuticals$292
- Mayne Pharma Commercial LLC$289
- AbbVie$276
- Amgen$251
- Exeltis, USA Inc.$166
- Agile Therapeutics, Inc.$135
- plus $991 from 25 others
What the payments were for
- Food & beverage$2,34097%
- Education$442%
- Gifts$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avion Pharmaceuticals | 39 | $292 |
| Mayne Pharma Commercial LLC | 15 | $289 |
| AbbVie(2 entities) | 17 | $276 |
| Amgen | 13 | $251 |
| Exeltis, USA Inc. | 10 | $166 |
| Agile Therapeutics, Inc. | 8 | $135 |
| Therapeuticsmd, Inc. | 8 | $120 |
| Duchesnay USA Incorporated | 12 | $111 |
| Millicent US Inc | 6 | $111 |
| Myovant Sciences Inc. | 3 | $71 |
| Astellas Pharma US Inc | 3 | $66 |
| Currax Pharmaceuticals LLC | 3 | $47 |
| Aspira Women's Health Inc | 2 | $42 |
| Pfizer | 3 | $41 |
| Radius Health, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Lupin Inc. | 2 | $25 |
| Exact Sciences | 1 | $25 |
| Avanos Medical | 1 | $24 |
| AMAG Pharmaceuticals, Inc. | 2 | $23 |
| Roche Diagnostics Corporation | 1 | $22 |
| Shield Therapeutics Inc | 1 | $22 |
| Mylan Pharmaceuticals Inc. | 1 | $21 |
| BD | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Ascend Therapeutics US, LLC | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $16 |
| Nalpropion Pharmaceuticals LLC | 1 | $14 |
| Coopersurgical, Inc. | 1 | $14 |
How this compares
$2,400 in reported general payments places this provider in the 70th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 23 | $2,202 |
| ProgesteroneProgesterone, Micronized | 13 | $682 |
| Levothyroxine Sodium | 15 | $159 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in New Braunfels
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.